Eyebright Medical Technology Beijing Co Ltd (688050) — Cash Flow-to-Debt Ratio
Eyebright Medical Technology Beijing Co Ltd (688050) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥76.92 Million could theoretically repay 0% of its total liabilities (CN¥894.96 Million) in one year. See 688050 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eyebright Medical Technology Beijing Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Eyebright Medical Technology Beijing Co Ltd across 10 annual periods. Also explore 688050 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Eyebright Medical Technology Beijing Co Ltd. For market capitalisation and broader financial context, see 688050 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CN¥369.15 Million | CN¥917.65 Million | ▼ -0.2% |
| 2024 | 0.40x | CN¥347.75 Million | CN¥862.71 Million | ▲ +25.7% |
| 2023 | 0.32x | CN¥226.27 Million | CN¥705.85 Million | ▼ -58.4% |
| 2022 | 0.77x | CN¥250.13 Million | CN¥324.30 Million | ▲ +8.1% |
| 2021 | 0.71x | CN¥219.30 Million | CN¥307.46 Million | ▼ -47.4% |
| 2020 | 1.36x | CN¥123.35 Million | CN¥90.89 Million | ▲ +2.8% |
| 2019 | 1.32x | CN¥50.49 Million | CN¥38.26 Million | ▲ +35.2% |
| 2018 | 0.98x | CN¥31.82 Million | CN¥32.59 Million | ▲ +1726.2% |
| 2017 | 0.05x | CN¥4.15 Million | CN¥77.62 Million | ▲ +172.8% |
| 2016 | -0.07x | CN¥-3.37 Million | CN¥45.88 Million | — |